Antara Capital LP
- SEC CIK
- 0001750183
- Latest filing
- Feb 17, 2026
IKT holding history
Inhibikase Therapeutics, Inc. in every 13F filed by Antara Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IKT overviewAll 13F holders of IKTFull Q4 2025 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −403,000−100.0% | Sold out | Holders |
| Q2 2022 | 403,000 | $299.0K | <0.1% | +100,000+33.0% | Added | Holders |
| Q1 2022 | 303,000 | $448.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 303,000 | $445.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 303,000 | $576.0K | 0.1% | +53,000+21.2% | Added | Holders |
| Q2 2021 | 250,000 | $700.0K | 0.1% | +250,000 | New | Holders |